As of 2025-07-19, the Relative Valuation of Jazz Pharmaceuticals PLC (JAZZ) is 170.72 USD. This relative valuation is based on P/E multiples. With the latest stock price at 112.87 USD, the upside of Jazz Pharmaceuticals PLC based on Relative Valuation is 51.3%.
The range of the Relative Valuation is 90.26 - 239.70 USD.
| Range | Selected | |
| Trailing P/E multiples | 23.8x - 30.1x | 29.6x |
| Forward P/E multiples | 18.6x - 23.0x | 21.8x |
| Fair Price | 90.26 - 239.70 | 170.72 |
| Upside | -20.0% - 112.4% | 51.3% |
| Date | P/E |
| 2025-07-18 | 14.16 |
| 2025-07-17 | 14.41 |
| 2025-07-16 | 14.57 |
| 2025-07-15 | 14.09 |
| 2025-07-14 | 13.98 |
| 2025-07-11 | 13.84 |
| 2025-07-10 | 14.11 |
| 2025-07-09 | 14.00 |
| 2025-07-08 | 13.69 |
| 2025-07-07 | 13.50 |
| 2025-07-03 | 13.73 |
| 2025-07-02 | 13.79 |
| 2025-07-01 | 13.73 |
| 2025-06-30 | 13.32 |
| 2025-06-27 | 13.41 |
| 2025-06-26 | 13.49 |
| 2025-06-25 | 13.44 |
| 2025-06-24 | 13.57 |
| 2025-06-23 | 13.40 |
| 2025-06-20 | 13.49 |
| 2025-06-18 | 13.58 |
| 2025-06-17 | 13.43 |
| 2025-06-16 | 13.76 |
| 2025-06-13 | 13.62 |
| 2025-06-12 | 13.84 |
| 2025-06-11 | 13.87 |
| 2025-06-10 | 14.18 |
| 2025-06-09 | 14.04 |
| 2025-06-06 | 13.95 |
| 2025-06-05 | 13.65 |
| 2025-06-04 | 13.73 |
| 2025-06-03 | 13.84 |
| 2025-06-02 | 13.59 |
| 2025-05-30 | 13.56 |
| 2025-05-29 | 13.59 |
| 2025-05-28 | 13.43 |
| 2025-05-27 | 13.74 |
| 2025-05-23 | 13.56 |
| 2025-05-22 | 13.53 |
| 2025-05-21 | 13.59 |
| 2025-05-20 | 13.93 |
| 2025-05-19 | 13.78 |
| 2025-05-16 | 13.68 |
| 2025-05-15 | 13.31 |
| 2025-05-14 | 13.38 |
| 2025-05-13 | 12.91 |
| 2025-05-12 | 13.00 |
| 2025-05-09 | 12.27 |
| 2025-05-08 | 12.35 |
| 2025-05-07 | 12.73 |